BioCentury | Jun 16, 1997
Emerging Company Profile

Lion Pharmaceuticals Inc.

Lion Pharmaceuticals Inc. Baltimore, Md. Technology: Access to disease-associated genomic targets Disease focus: NA Clinical status: NA Founded: 1996 by Johns Hopkins University School of Medicine and Robert Curtis Corporate partners: None University collaborators: Johns...
BioCentury | Jun 16, 1997
Emerging Company Profile

A pride of Lions: Sequencing and bioinformatics speedway; Revving the discovery engine

...Biotech companies formed by universities to commercialize academic research are not a new phenomenon. But Lion Pharmaceuticals Inc....
...Biotech companies formed by universities to commercialize academic research are not a new phenomenon. But Lion Pharmaceuticals Inc....
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals board of directors update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Appointed: Michael Antonaccio, Ph.D.; formerly VP of strategic drug development at Human Genome Sciences Inc. (HGSI, Rockville, Md.) WIR Staff...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals management update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Hired: Robert Curtis, Pharm.D., as president and CEO; formerly president and CEO of CombiChem Inc. (San Diego, Calif.); Michael Antonaccio, Ph.D., as CSO; formerly VP of strategic...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals scientific advisory board update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Appointed from Johns Hopkins University: Franklin Adkinson, M.D., interim vice dean of research and professor of medicine; Jeremy Berg, Ph.D., professor and director of biophysics and biophysical...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals, Johns Hopkins University deal

...partnerships. Johns Hopkins said it has a sizable but not majority equity stake in Lion. Lion Pharmaceuticals Inc....
Items per page:
1 - 6 of 6
BioCentury | Jun 16, 1997
Emerging Company Profile

Lion Pharmaceuticals Inc.

Lion Pharmaceuticals Inc. Baltimore, Md. Technology: Access to disease-associated genomic targets Disease focus: NA Clinical status: NA Founded: 1996 by Johns Hopkins University School of Medicine and Robert Curtis Corporate partners: None University collaborators: Johns...
BioCentury | Jun 16, 1997
Emerging Company Profile

A pride of Lions: Sequencing and bioinformatics speedway; Revving the discovery engine

...Biotech companies formed by universities to commercialize academic research are not a new phenomenon. But Lion Pharmaceuticals Inc....
...Biotech companies formed by universities to commercialize academic research are not a new phenomenon. But Lion Pharmaceuticals Inc....
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals board of directors update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Appointed: Michael Antonaccio, Ph.D.; formerly VP of strategic drug development at Human Genome Sciences Inc. (HGSI, Rockville, Md.) WIR Staff...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals management update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Hired: Robert Curtis, Pharm.D., as president and CEO; formerly president and CEO of CombiChem Inc. (San Diego, Calif.); Michael Antonaccio, Ph.D., as CSO; formerly VP of strategic...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals scientific advisory board update

Lion Pharmaceuticals Inc., Baltimore, Md. Business: Drug discovery Appointed from Johns Hopkins University: Franklin Adkinson, M.D., interim vice dean of research and professor of medicine; Jeremy Berg, Ph.D., professor and director of biophysics and biophysical...
BioCentury | Jun 9, 1997
Company News

Lion Pharmaceuticals, Johns Hopkins University deal

...partnerships. Johns Hopkins said it has a sizable but not majority equity stake in Lion. Lion Pharmaceuticals Inc....
Items per page:
1 - 6 of 6